| Field | Detail | Source |
|---|---|---|
| Legal name | Ajooni Biotech Limited | Annual Report FY2025-26 |
| Former name | Ajooni Biotech Private Limited (17 Feb 2010 – 27 Sep 2017) | Rights issue Letter of Offer 2024; ICICI Direct profile |
| Founding / incorporation date | 17 February 2010, at Chandigarh | Letter of Offer 2024 |
| Conversion to public company | 27 September 2017 (fresh certificate of incorporation, RoC Chandigarh) | Letter of Offer 2024 |
| Incorporation jurisdiction | India; Registrar of Companies, Chandigarh (Punjab) | Letter of Offer 2024 |
| Corporate Identification Number | L85190PB2010PLC040162 | Annual Report FY2025-26 |
| Registered office | D-118, Industrial Area, Phase VII, Mohali, Punjab 160055 (the AGM notice also uses PIN 160059) | Annual Report FY2025-26 |
| Corporate office | House No. 1769, Phase 3B2, Mohali, Punjab 160055 | Annual Report FY2025-26 |
| Manufacturing works | Gaib Di Pulli, Village Bullepur, Tehsil Khanna, District Ludhiana, Punjab 141401 (G.T. Road, Khanna) | Annual Report FY2025-26 |
| Stock exchange and ticker (current) | National Stock Exchange of India, Main Board — symbol AJOONI | NSE filings 2026 |
| Stock exchange and ticker (historical) | NSE Emerge (SME), listed 2 Jan 2018 — migrated May 2022 | Letter of Offer 2024; press release Dec 2022 |
| BSE | Several data vendors display BSE code 535040, but the company states its shares are listed only on NSE, and Upstox reports it as not listed on BSE | Directors' Report FY26 (Listing Fees section); Upstox |
| ISIN | INE820Y01021 (current, after the October 2022 split); INE820Y01013 (pre-split) | Directors' Report FY26; investor presentation June 2022 |
| CUSIP | Not applicable (no US listing) | — |
| Fiscal year end | 31 March | Annual Report FY2025-26 |
| Employees | 134 (latest, per Morningstar). A 3-year headcount trend is not publicly disclosed in the documents reviewed. Employee benefit expense rose from INR 1.80 Cr (FY24) to 2.76 Cr (FY25) and 4.57 Cr (FY26), which indicates a material workforce expansion linked to the new plant and the B2C dealer push | Morningstar; CMOTS; Annual Report FY26 |
| Statutory auditor | M/s Narinder Kumar and Company, Chartered Accountants, Mohali (FRN 0030737N; Peer Review Certificate 016014; engagement partner Narinder Kumar Garg, M.No. 080287). Appointed at the 14th AGM (17 Sep 2024) for five years to the 19th AGM (2029) | Directors' Report FY26; Q1 FY27 Limited Review Report |
| Secretarial auditor | M/s SDK & Associates, Punjab (PRC 7065/2025), FY2025-26 to FY2029-30 | Directors' Report FY26 |
| Registrar and transfer agent | Cameo Corporate Services Ltd, Chennai | Annual Report FY2025-26 |
| Banker | HDFC Bank Limited, G.T. Road, Khanna | Annual Report FY2025-26 |
| Shares outstanding | 18,12,43,598 equity shares of INR 2 each, after the allotment of 90,00,000 shares on 12 Aug 2026; 17,22,43,598 as at 31 Mar 2026 | AGM Notice 2026; NSE allotment filing 12 Aug 2026 |
| Market capitalisation (latest verified) | About INR 65–70 Cr. Share price INR 3.79–3.90 between 28 Aug and 10 Sep 2026; Value Research showed INR 70 Cr on 1 Sep 2026. No quote for 19 Oct 2026 could be independently verified | Anand Rathi; Value Research; Torus Digital |
| Website | https://ajoonibiotech.com | Annual Report FY2025-26 |
The supplied identifiers (ticker "AJOONI-SM.NS", exchange "National Stock Exchange of India") refer to the company's original listing on the NSE Emerge SME platform. That listing is outdated. Ajooni Biotech listed on NSE Emerge on 2 January 2018 and migrated to the NSE Main Board in May 2022 (source: rights issue press coverage, December 2022). The equity now trades under the symbol AJOONI on the NSE Main Board, and the NSE's Q2 FY26 integrated filing classifies the company as "Main Board". The entity profiled is unchanged: Ajooni Biotech Limited, CIN L85190PB2010PLC040162, website ajoonibiotech.com, India, NSE: AJOONI.
Ajooni Biotech is a Punjab-based micro-cap manufacturer of compound cattle feed, feed chips, camel feed, oil cakes and mineral and feed supplements. It positions itself as India's first listed "PURE VEG." animal-nutrition company, meaning formulations free of animal-derived inputs. The company runs a hybrid model. Historically most revenue has come from B2B and contract manufacturing for institutional buyers such as IFFCO Kisan, Mother Dairy, Paras (VRS Foods), Saahaj Dairy, NDDB Dairy Services and Patanjali-branded supplements. Since May 2024 it has also built its own "Ajooni" brand through a dealer network in north India. In FY26 a new Khanna plant tripled capacity to 1.8 lakh MTPA, and revenue rose 59% to INR 182.4 Cr. Margins, however, remain thin: EBITDA excluding other income was about 3.4% and PAT 2.4%. Returns on equity are about 5%. Large customer orders, promoter-group related-party ties and repeated equity dilution define the investment case.
---
### The company's own description (Annual Report FY2025-26, paraphrased)
The FY26 Annual Report describes Ajooni as one of India's leading providers of animal nutrition and animal healthcare solutions. Its stated purpose is to raise dairy-farm productivity and livestock performance with scientifically formulated products. The portfolio spans compound cattle feed, cattle feed chips, camel feed, cotton oil cake, mustard oil cake and a range of feed supplements covering the livestock life cycle.
The company says it works with universities, research institutions and independent scientists on product development. It cites certifications under ISO 9001:2015, ISO 14001 (stated as "ISO:14000:2015"), ISO 45001 (stated as "ISO:45000:2018") and the ZED Gold scheme, together with BIS registration for ISI-marked feed and supplements. It also reports integrated ERP, PLC-based automated production controls, and environmental features at the plant (solar power, rainwater harvesting, a sewage treatment plant). Finally, it highlights a team of veterinary doctors and a field marketing force that provide doorstep technical service to customers.
For segment reporting, the Q1 FY27 results describe the business as a single segment ("Manufacturing of cattle feed and supplements") under Ind AS 108.
### Independent characterisation
Ajooni is best understood as a regional, low-margin feed converter with an emerging brand layer:
1. **Contract and institutional manufacturing core (B2B).** Ajooni makes feed to the specifications of large buyers, including cooperatives, agri-input marketers (IFFCO Kisan under an exclusive agreement from March 2020) and branded marketers (Patanjali Gramodhyog Nyas for Patanjali Samvriddhi, Garbhanjali and Batisa-Pro). These are high-volume, thin-margin relationships. Buyers have considerable pricing power because they can switch suppliers and dairy cooperatives cap feed prices to retain members (Mordor Intelligence notes this pressure on manufacturers' margins). The ₹47.52 Cr order from one existing customer in February 2026, about 26% of FY26 revenue (derived), shows how concentrated this channel is.
2. **Own-brand B2C channel.** Launched in May 2024 in three states, including Punjab and Rajasthan. The company reported more than 100 dealers and a target of more than 300 distribution points (press release, 15 May 2024). Products include Gold Pashu Aahar, Buff Plus, 3 Star, 4 Star, Calf Starter and Transition Plus feeds, plus Calvit, Batisa, Liv and Min supplements (Morningstar company profile). The brand channel should carry better margins but needs working capital for dealer credit and inventory.
3. **Commodity trading and processing adjacencies.** Cotton oil cake and mustard oil cake are by-products traded as feed ingredients. Their prices follow oilseed cycles.
4. **Optionality projects of uncertain status.** In May 2024 the company announced moringa cultivation at Derabassi, Punjab, aimed at nutraceutical, feed and biodiesel uses, with management projecting an additional ₹150–200 Cr of annual revenue. No subsequent filing reviewed quantifies progress, so this should be treated as unproven.
**Revenue model mix.** Ajooni earns essentially all its revenue from product sales. It has no service, subscription or licensing income. The split between contract/B2B and own-brand sales is not publicly disclosed. Other income was ₹2.42 Cr in FY26, or 1.3% of revenue (Directors' Report FY26). This is a material share of a profit base of only ₹5.74 Cr PBT.
**Value-chain position.** The company sits mid-stream. It buys grains, de-oiled cakes, brans, molasses, minerals and vitamins. It processes them by grinding, mixing and pelleting or chipping, then sells feed to cooperatives, agri-marketers, dealers and, to a small extent, export customers (Avon Animal Health orders; exports "to two countries" per a 2024 DSIJ report). It neither owns herds nor controls milk procurement, so it captures none of the downstream dairy margin.
**Customer types:** (i) dairy cooperatives and milk processors, including Mother Dairy, Paras Dairy/VRS Foods, Saahaj Dairy and an unnamed "leading dairy cooperative" that placed a ₹25 Cr repeat order in August 2025; (ii) agri-input marketers (IFFCO Kisan); (iii) branded marketers (Patanjali Gramodhyog Nyas); (iv) government and quasi-government dairy bodies (NDDB Dairy Services contract, 2024; Directorate of Dairy Development, Punjab, cited in presentations); (v) dealers and farmers under the Ajooni brand; and (vi) small export customers.
**End-markets:** dairy cattle and buffalo nutrition, which is the core, plus camel feed (a niche relevant to Rajasthan) and adjacent feed-ingredient trading.